Role of Biomarkers in Prediction of Cardiotoxicity During Cancer Treatment

Current Treatment Options in Cardiovascular Medicine - United States
doi 10.1007/s11936-018-0641-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

MicroRNAs in Cancer Treatment-Induced Cardiotoxicity

Cancers
Cancer ResearchOncology
2020English

Trastuzumab in the Treatment of Metastatic Breast Cancer : Anticancer Therapy Versus Cardiotoxicity

Circulation
Cardiovascular MedicinePhysiologyCardiology
2000English

Bortezomib-Induced Complete Heart Block and Myocardial Scar: The Potential Role of Cardiac Biomarkers in Monitoring Cardiotoxicity

Case Reports in Cardiology
Cardiovascular MedicineCardiology
2016English

HER2+ Breast Cancer Treatment and Cardiotoxicity: Monitoring and Management

Breast Cancer Research and Treatment
Cancer ResearchOncology
2019English

The Role of Prostate Cancer Biomarkers in Undiagnosed Men

Current Opinion in Urology
Urology
2017English

Role of Nebivolol in Anthracycline-Induced Cardiotoxicity

International Journal of Research in Medical Sciences
2019English

Cancer Biomarkers: The Role of Structured Data Reporting

Archives of Pathology and Laboratory Medicine
MedicineForensic MedicinePathologyMedical Laboratory Technology
2015English

The Role of Tumor Markers and Biomarkers in Colorectal Cancer

Neoplasma
Cancer Research
2014English

Comparative Effectiveness of Biomarkers to Target Cancer Treatment

Medical Decision Making
Health Policy
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy